ChromaDex Corporation (NASDAQ:CDXC)’s traded shares stood at 439,576 during the last session, with the company’s beta value hitting 1.68. At the close of trading, the stock’s price was $8.94, to imply an increase of 2.64% or $0.23 in intraday trading. The CDXC share’s 52-week high remains $23.66, putting it -164.65% down since that peak but still an impressive +57.27% since price per share fell to its 52-week low of $3.82. The company has a valuation of $607.32 Million, with an average of 329.97 Million shares in intraday trading volume over the past 10 days and average of 1.28 Million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for ChromaDex Corporation (CDXC), translating to a mean rating of 1.6. Of 5 analyst(s) looking at the stock, none analyst(s) give CDXC a Sell rating. None of those analysts rate the stock as Overweight while no one advise Hold as 5 recommend it as a Buy. None analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$0.08.
After registering a 2.64% upside in the last session, ChromaDex Corporation (CDXC) has traded green over the past five days. The stock hit a weekly high of $9.00- this Thursday, Jun 03, jumping 0.67% in its intraday price action. The 5-day price performance for the stock is 6.94%, and 2.41% over 30 days. With these gigs, the year-to-date price performance is 86.25%. Short interest in ChromaDex Corporation (NASDAQ:CDXC) saw shorts transact 4.83 Million shares and set a 3.77 days time to cover.
Analysts on Wall Street suggest a consensus price target of $15, implying an increase of 67.79% to the stock’s current value. The extremes give us $11 and $18 for target low and target high price respectively. As such, CDXC has been trading 101.34% off suggested target high and 23.04% from its likely low.
ChromaDex Corporation (CDXC) estimates and forecasts
An assessment of the company’s 5-year growth patterns shows that annual earnings fell an estimated -33.4% for the past 5-year period. While 2021 is set for a 42.1% return in earnings, projections for the next 5 years are at 0% annually.
ChromaDex Corporation (NASDAQ:CDXC)’s Major holders
ChromaDex Corporation insiders hold 33.14% of total outstanding shares, with institutional holders owning 36.45% of the shares at 54.51% float percentage. In total, 123 institutions holds shares in the company, led by Yong Rong (HK) Asset Management Ltd. As of Mar 30, 2021, the company held over 4.13 Million shares (or 6.08% of shares), all amounting to roughly $38.59 Million.
The next major institution holding the largest number of shares is Blackrock Inc. with 3.17 Million shares, or about 4.67% of shares outstanding. As of the market price on Mar 30, 2021, these shares were worth $29.63 Million.
Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.
Add them to your watchlist before they take off!
We also have Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the ChromaDex Corporation (CDXC) shares. Going by data provided on Dec 30, 2020, Vanguard Total Stock Market Index Fund holds roughly 1,563,363 shares. This is just over 2.3% of the total shares, with a market valuation of $7.5 Million. Data from the same date shows that the other fund manager holds a little less at 1.02 Million, or 1.51% of the shares, all valued at about $9.57 Million.